Search Results - "HANSEN, Bo F"

Refine Results
  1. 1

    A novel high-affinity peptide antagonist to the insulin receptor by Schäffer, Lauge, Brand, Christian L., Hansen, Bo F., Ribel, Ulla, Shaw, Allan C., Slaaby, Rita, Sturis, Jeppe

    “…In this publication we describe a peptide insulin receptor antagonist, S661, which is a single chain peptide of 43 amino acids. The affinity of S661 for the…”
    Get full text
    Journal Article
  2. 2

    Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10 by Hansen, Bo F, Glendorf, Tine, Hegelund, Anne C, Lundby, Anders, Lützen, Anne, Slaaby, Rita, Stidsen, Carsten Enggaard

    Published in PloS one (08-05-2012)
    “…There is controversy with respect to molecular characteristics of insulin analogues. We report a series of experiments forming a comprehensive characterisation…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Dysregulation of Glycogen Synthase COOH- and NH2-Terminal Phosphorylation by Insulin in Obesity and Type 2 Diabetes Mellitus by Højlund, Kurt, Birk, Jesper B., Klein, Ditte K., Levin, Klaus, Rose, Adam J., Hansen, Bo F., Nielsen, Jakob N., Beck-Nielsen, Henning, Wojtaszewski, Jørgen F. P.

    “…Context: Insulin-stimulated glucose disposal is impaired in obesity and type 2 diabetes mellitus (T2DM) and is tightly linked to impaired skeletal muscle…”
    Get full text
    Journal Article
  5. 5

    Isoform‐specific and exercise intensity‐dependent activation of 5′‐AMP‐activated protein kinase in human skeletal muscle by Wojtaszewski, Jørgen F. P., Nielsen, Pernille, Hansen, Bo F., Richter, Erik A., Kiens, Bente

    Published in The Journal of physiology (01-10-2000)
    “…1 5′‐AMP‐activated protein kinase (AMPK) has been suggested to play a key role in the regulation of metabolism in skeletal muscle. AMPK is activated in…”
    Get full text
    Journal Article
  6. 6

    Synthesis and in Vitro Characterization of 1-(4-Aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic Acid Derivatives. A New Class of Selective GSK-3 Inhibitors by Olesen, Preben H, Sørensen, Anders R, Ursø, Birgitte, Kurtzhals, Peter, Bowler, Andrew N, Ehrbar, Ulrich, Hansen, Bo F

    Published in Journal of medicinal chemistry (17-07-2003)
    “…A novel class of GSK-3 inhibitors with favorable water solubility was identified in a HTS screen. SAR studies identified bioisosteric structural moieties in…”
    Get full text
    Journal Article
  7. 7

    Systematic evaluation of the metabolic to mitogenic potency ratio for B10-substituted insulin analogues by Glendorf, Tine, Knudsen, Louise, Stidsen, Carsten E, Hansen, Bo F, Hegelund, Anne Charlotte, Sørensen, Anders R, Nishimura, Erica, Kjeldsen, Thomas

    Published in PloS one (22-02-2012)
    “…Insulin analogues comprising acidic amino acid substitutions at position B10 have previously been shown to display increased mitogenic potencies compared to…”
    Get full text
    Journal Article
  8. 8

    Caffeine-Induced Impairment of Insulin Action but Not Insulin Signaling in Human Skeletal Muscle Is Reduced by Exercise by THONG, Farah S. L, DERAVE, Wim, KIENS, Bente, GRAHAM, Terry E, URSØ, Birgitte, WOJTASZEWSKI, Jørgen F. P, HANSEN, Bo F, RICHTER, Erik A

    Published in Diabetes (New York, N.Y.) (01-03-2002)
    “…Caffeine-Induced Impairment of Insulin Action but Not Insulin Signaling in Human Skeletal Muscle Is Reduced by Exercise Farah S.L. Thong 1 , Wim Derave 2 ,…”
    Get full text
    Journal Article
  9. 9

    Phosphorylation-dependent Translocation of Glycogen Synthase to a Novel Structure during Glycogen Resynthesis by Prats, Clara, Cadefau, Joan A, Cussó, Roser, Qvortrup, Klaus, Nielsen, Jakob N, Wojtaszewski, Jørgen F P, Wojtaszewki, Jørgen F P, Hardie, D Grahame, Stewart, Greg, Hansen, Bo F, Ploug, Thorkil

    Published in The Journal of biological chemistry (17-06-2005)
    “…Glycogen metabolism has been the subject of extensive research, but the mechanisms by which it is regulated are still not fully understood. It is well accepted…”
    Get full text
    Journal Article
  10. 10

    Insulin signaling in human skeletal muscle: Time course and effect of exercise by WOJTASZEWSKI, J. F. P, HANSEN, B. F, KIENS, B, RICHTER, E. A

    Published in Diabetes (New York, N.Y.) (01-11-1997)
    “…Activation of early steps in the insulin signaling cascade in human skeletal muscle was investigated using a one-step euglycemic-hyperinsulinemic…”
    Get full text
    Journal Article
  11. 11

    Increased insulin receptor binding and increased IGF-1 receptor binding are linked with increased growth of L6hIR cell xenografts in vivo by Hvid, Henning, Glendorf, Tine, Brandt, Jakob, Slaaby, Rita, Lützen, Anne, Kristensen, Kim, Hansen, Bo F.

    Published in Scientific reports (29-04-2020)
    “…Insulin analogue X10 has a higher mitogenic potency than native human insulin in vitro and supra-pharmacological doses of insulin X10 increased the incidence…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome by Kanter, Jenny E, Kramer, Farah, Barnhart, Shelley, Duggan, Jeffrey M, Shimizu-Albergine, Masami, Kothari, Vishal, Chait, Alan, Bouman, Stephan D, Hamerman, Jessica A, Hansen, Bo F, Olsen, Grith S, Bornfeldt, Karin E

    Published in Diabetes (New York, N.Y.) (01-05-2018)
    “…Cardiovascular disease caused by atherosclerosis is the leading cause of mortality associated with type 2 diabetes and metabolic syndrome. Insulin therapy is…”
    Get full text
    Journal Article
  14. 14

    Activation of insulin receptors and IGF-1 receptors in COLO-205 colon cancer xenografts by insulin and insulin analogue X10 does not enhance growth under normo- or hypoglycaemic conditions by Hvid, Henning, Jørgensen, Mikkel S., Blume, Niels, Slaaby, Rita, Lützen, Anne, Hansen, Bo F.

    Published in Diabetologia (01-11-2018)
    “…Aims/hypothesis Recent studies with normal rats and mouse allograft models have reported that insulin and insulin analogues do not activate the IGF-1 receptor…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues by Baricevic, Ivona, Jones, David R, Roberts, Darren L, Lutzen, Anne, Lundby, Anders, Worm, Jesper, Hansen, Bo F, Renehan, Andrew G

    Published in Carcinogenesis (New York) (01-09-2015)
    “…Epidemiological and laboratory studies raise the possibility of a link between clinically prescribed insulin analogues and increased cancer risk. Accordingly,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    802-P: Beneficial Effects of a Functionally Selective Insulin on Vascular Function and Liver Triglycerides by OLSEN, GRITH S., PEDERSEN, THOMAS A., SLAABY, RITA, HANSEN, BO F., GLENDORF, TINE, DEMOZAY, DAMIEN, HVID, HENNING, NISHIMURA, ERICA, BRANDT, JAKOB, POVLEN, GRO

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Selective insulin resistance, where insulin's ability to lower blood glucose via the Akt signaling pathway gradually decreases while retaining its…”
    Get full text
    Journal Article
  19. 19

    Wortmannin inhibits both insulin- and contraction-stimulated glucose uptake and transport in rat skeletal muscle by Wojtaszewski, Jorgen F. P, Hansen, Bo F, Urso, Birgitte, Richter, Erik A

    Published in Journal of applied physiology (1985) (01-10-1996)
    “…Jørgen F. P. Wojtaszewski, Bo F. Hansen, Birgitte Ursø, and Erik A. Richter Copenhagen Muscle Research Centre, August Krogh Institute, University of…”
    Get full text
    Journal Article
  20. 20

    Surface-expressed insulin receptors as well as IGF-I receptors both contribute to the mitogenic effects of human insulin and its analogues by Lundby, Anders, Bolvig, Pernille, Hegelund, Anne Charlotte, Hansen, Bo F., Worm, Jesper, Lützen, Anne, Billestrup, Nils, Bonnesen, Christine, Oleksiewicz, Martin B.

    Published in Journal of applied toxicology (01-07-2015)
    “…There is a medical need for new insulin analogues. Yet, molecular alterations to the insulin molecule can theoretically result in analogues with carcinogenic…”
    Get full text
    Journal Article